Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Hemoglobin levels, hematocrit and pregnancy outcome].
Knottnerus JA, Delgado LR, Knipschild PG, Essed GG, Smits F. Knottnerus JA, et al. Among authors: delgado lr. Ned Tijdschr Geneeskd. 1988 Apr 16;132(16):719-23. Ned Tijdschr Geneeskd. 1988. PMID: 3374652 Dutch. No abstract available.
Maternal haemoglobin and pregnancy outcome.
Knottnerus JA, Delgado L, Knipschild PG, Essed GG, Smits F. Knottnerus JA, et al. Lancet. 1986 Aug 2;2(8501):282. doi: 10.1016/s0140-6736(86)92096-9. Lancet. 1986. PMID: 2874300 No abstract available.
Smoking in Dutch pregnant women and birth weight.
Adriaanse HP, Knottnerus JA, Delgado LR, Cox HH, Essed GG. Adriaanse HP, et al. Patient Educ Couns. 1996 Jun;28(1):25-30. doi: 10.1016/0738-3991(95)00798-9. Patient Educ Couns. 1996. PMID: 8852204 Review.
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
Diaz de la Guardia R, Lopez-Millan B, Lavoie JR, Bueno C, Castaño J, Gómez-Casares M, Vives S, Palomo L, Juan M, Delgado J, Blanco ML, Nomdedeu J, Chaparro A, Fuster JL, Anguita E, Rosu-Myles M, Menéndez P. Diaz de la Guardia R, et al. Stem Cell Reports. 2017 Jun 6;8(6):1573-1586. doi: 10.1016/j.stemcr.2017.04.019. Epub 2017 May 18. Stem Cell Reports. 2017. PMID: 28528702 Free PMC article.
We report a functional, genetic, and immunological characterization of BM-MSC cultures from 46 AML patients, stratified by molecular/cytogenetics into low-risk (LR), intermediate-risk (IR), and high-risk (HR) subgroups. Stable MSC cultures were successfully established and …
We report a functional, genetic, and immunological characterization of BM-MSC cultures from 46 AML patients, stratified by molecular/cytogen …
Sublethal microcystin exposure and biochemical outcomes among hemodialysis patients.
Hilborn ED, Soares RM, Servaites JC, Delgado AG, Magalhães VF, Carmichael WW, Azevedo SM. Hilborn ED, et al. PLoS One. 2013 Jul 24;8(7):e69518. doi: 10.1371/journal.pone.0069518. Print 2013. PLoS One. 2013. PMID: 23894497 Free PMC article.
Serum microcystin concentrations were quantified with enzyme-linked immunosorbent assay which measures free serum microcystin LR equivalents (ME). We describe serum ME concentrations and biochemical outcomes among a subset of patients during 8 weeks following exposure. ...
Serum microcystin concentrations were quantified with enzyme-linked immunosorbent assay which measures free serum microcystin LR equi …
The removal of endocrine disrupting compounds, pharmaceutically activated compounds and cyanobacterial toxins during drinking water preparation using activated carbon--a review.
Delgado LF, Charles P, Glucina K, Morlay C. Delgado LF, et al. Sci Total Environ. 2012 Oct 1;435-436:509-25. doi: 10.1016/j.scitotenv.2012.07.046. Epub 2012 Aug 10. Sci Total Environ. 2012. PMID: 22885596 Review.
This paper provides a review of recent scientific research on the removal by activated carbon (AC) in drinking water (DW) treatment of 1) two classes of currently unregulated trace level contaminants with potential chronic toxicity-pharmaceutically activate compounds (PhACs) and …
This paper provides a review of recent scientific research on the removal by activated carbon (AC) in drinking water (DW) treatment of 1) tw …
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page